Algert Global LLC Acquires New Position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT)

Algert Global LLC acquired a new position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The firm acquired 91,820 shares of the company’s stock, valued at approximately $952,000. Algert Global LLC owned 0.16% of Phathom Pharmaceuticals at the end […]

Leave a Reply

Your email address will not be published.

Previous post Algert Global LLC Reduces Position in McGrath RentCorp (NASDAQ:MGRC)
Next post Algert Global LLC Increases Holdings in Hawkins, Inc. (NASDAQ:HWKN)